37169-46-3

Upstream product

• 13139-17-8 N-(Benzyloxycarbonyloxy)succinimide 
• 1421-65-4 L-dopa methyl ester hydrochloride 
• 501-53-1 benzyl chloroformate 
• 109-02-4 4-methyl-morpholine 
• 59-92-7 levodopa 

Downstream Products

• 130336-18-4 N-(Benzyloxycarbonyl)-L-<3,4-(1,4,7,10-tetraoxadecamethylene)phenyl>alanine methyl ester 
• 1246370-69-3 (S)-methyl 3-(3,4-bis(benzyloxy)phenyl)-2-(benzyloxycarbonylamino)propanoate 
• 35591-10-7 (S)-3-(3,4-bis(benzyloxy)phenyl)-2-(benzyloxycarbonylamino)propanoic acid 
• 208051-63-2 N-(benzyloxycarbonyl)-3-(3,4-ethylenedioxyphenyl)-L-alanine methyl ester 

Relevant academic research and scientific papers

GLYCOAMINO ACID AND USE THEREOF

An object of the present invention is to provide an amino acid precursor which shows improvement in the properties (particularly water-solubility, stability in water, bitter taste etc.) of amino acid, and can be converted to amino acid in vivo etc. The present invention relates to a compound for an amino acid precursor, which is a compound represented by the formula (I): wherein each symbol is as described in the DESCRIPTION, or a salt thereof.

Design, synthesis and biological evaluation of l-dopa amide derivatives as potential prodrugs for the treatment of Parkinson's disease

A range of amide derivatives of l-dopa were synthesized and investigated for their pharmacological activity and their ability to be converted to l-dopa using the unilaterally 6-hydroxydopamine (6-OHDA)-lesioned rat, as an experimental model of Parkinson's

1,2-Benzothiazine 1,1-dioxide P2-P3 peptide mimetic aldehyde calpain I inhibitors

A series of peptide mimetic aldehyde inhibitors of calpain I was prepared in which the P2 and P3 amino acids were replaced by substituted 3,4-dihydro-1,2-benzothiazine-3-carboxylate 1,1-dioxides. The effect of 2, 6, and 7-benzothiazi

BENZOTHIAZO AND RELATED HETEROCYCLIC GROUP-CONTAINING CYSTEINE AND SERINE PROTEASE INHIBITORS

The present invention is directed to novel benzothiazo and related heterocyclic group-containing inhibitors of cysteine or serine proteases. Methods for using the same are also described.